Factors associated with progression from parainfluenza virus-3 upper respiratory infections to lower respiratory tract infections among allogeneic hematopoietic stem cell transplant recipients in multivariable analysis
| Covariate . | Odds ratio . | 95% CI . | P . |
|---|---|---|---|
| Donor CMV serostatus | |||
| Negative | 1.0 | — | — |
| Positive | 2.1 | 1.0-4.6 | .06 |
| Corticosteroid dose | |||
| None | 1.0 | — | — |
| Less than 1 mg/kg/d | 2.8 | 0.8-9.9 | .10 |
| 1 − less than 2 mg/kg/d | 8.6 | 2.6-27.8 | .0003 |
| At least 2 mg/kg/d | 19.8 | 5.2-74.6 | < .0001 |
| Covariate . | Odds ratio . | 95% CI . | P . |
|---|---|---|---|
| Donor CMV serostatus | |||
| Negative | 1.0 | — | — |
| Positive | 2.1 | 1.0-4.6 | .06 |
| Corticosteroid dose | |||
| None | 1.0 | — | — |
| Less than 1 mg/kg/d | 2.8 | 0.8-9.9 | .10 |
| 1 − less than 2 mg/kg/d | 8.6 | 2.6-27.8 | .0003 |
| At least 2 mg/kg/d | 19.8 | 5.2-74.6 | < .0001 |
Not significant: patient/donor age, donor type, patient CMV serostatus, disease risk, receipt of total body irradiation, engraftment status, graft-versus-host disease.
CMV indicates cytomegalovirus; CI, confidence interval.